fibrinogen has been researched along with Allergy, Drug in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buonomo, A; De Pasquale, TM; Di Gennaro, L; Pucci, S | 1 |
| Gröner, A; Pendrak, I; Solomon, C; Ye, J | 1 |
| PERKINS, HA; TRINKNER, RL | 1 |
| de Bono, DP | 1 |
| Douglas, AS | 1 |
| Campese, VM; Coratelli, P; Marzullo, F; Schena, FP | 1 |
| Galton, DA; Hamilton-Fairley, G; Malpas, JS | 1 |
| Quaglino, D; Storti, E | 1 |
3 review(s) available for fibrinogen and Allergy, Drug
| Article | Year |
|---|---|
Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance data.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Drug Contamination; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinogen; Hemostatics; Hepatitis B; Hepatitis C; Humans; Male; Middle Aged; Patient Safety; Pharmacovigilance; Risk Assessment; Risk Factors; Thromboembolism; Time Factors; Young Adult | 2015 |
Complications of thrombolysis and their clinical management.
Topics: Anticoagulants; Drug Hypersensitivity; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Hemostasis; Humans; Risk Factors; Thrombolytic Therapy | 1993 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
5 other study(ies) available for fibrinogen and Allergy, Drug
| Article | Year |
|---|---|
Pulmonary Embolism After Ceftriaxone-Induced Anaphylaxis.
Topics: Aged; Anaphylaxis; Anti-Bacterial Agents; Ceftriaxone; Drug Hypersensitivity; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoglobulin E; Male; Pulmonary Embolism; Saphenous Vein; Thrombophlebitis; Tomography, X-Ray Computed; Ultrasonography | 2017 |
SEVERE ACUTE FIBRINOGENOPENIA APPARENTLY CAUSED BY REACTION TO DRUGS.
Topics: Afibrinogenemia; Blood Coagulation Tests; Diatrizoate; Diphenhydramine; Diuretics; Drug Hypersensitivity; Fibrinogen; Hemostatics; Humans; Hydrocortisone; Hypotension; Organomercury Compounds; Toxicology | 1964 |
Acute renal failure during intermittent rifampicin therapy.
Topics: Acute Kidney Injury; Adult; Anuria; Drug Hypersensitivity; Fibrinogen; Fluorescent Antibody Technique; Furosemide; Humans; Immunoglobulins; Male; Rifampin; Tuberculosis, Pulmonary | 1973 |
Clinical experience with L-asparaginase.
Topics: Asparaginase; Bone Marrow Cells; Child; Drug Hypersensitivity; Erwinia; Escherichia coli; Female; Fibrinogen; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Liver Function Tests; Lymphoma, Non-Hodgkin; Melanoma; Nausea; Serum Albumin; Species Specificity; Vomiting | 1970 |
Dysmetabolic and neurological complications in leukemia patients treated with L-asparaginase.
Topics: Asparaginase; Central Nervous System Diseases; Child; Clinical Enzyme Tests; Drug Hypersensitivity; Feeding and Eating Disorders; Female; Fibrinogen; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lipids; Male; Metabolic Diseases; Middle Aged; Nausea; Prothrombin Time; Uric Acid; Vomiting | 1970 |